Remember the financial crisis of 2008? Insmed had failed MMD trial and our money was nearly exhausted. Then suddenly....
You don't remember?
Allan waived his hand and 130 million from Merck was created. Well, it was a bit more involved than that, but the point is our current CEO is in a much stronger position and despite this market crisis, the next deal will be a cash partnership for NTM worldwide which could outdo even the Merck deal from 2008. This deal is independent of the market price manipulation accomplished by our greedy biotech short hedgies. Their time is coming, and yesterday they overshot their target, neutering their ability to drive the price down any further today or tomorrow. So, buck up, buy shares and be patient as Lewis negotiates a stellar deal and with a foreign entity and the FDA. The larger the short position, the worse they will have it when the news breaks!